AI Article Synopsis

  • Cephalostatin 1, OSW-1, ritterazine B, and schweinfurthin A are natural compounds that inhibit the growth of human cancer cells but their exact cellular targets were initially unknown.
  • Recent research identified these compounds as targeting oxysterol binding protein (OSBP) and its related protein ORP4L, which are not previously linked to cancer cell survival.
  • The compounds, now termed ORPphilins, serve as tools to explore the cellular functions of OSBP and ORP4L, potentially revealing their roles in human diseases.

Article Abstract

Cephalostatin 1, OSW-1, ritterazine B and schweinfurthin A are natural products that potently, and in some cases selectively, inhibit the growth of cultured human cancer cell lines. The cellular targets of these small molecules have yet to be identified. We have discovered that these molecules target oxysterol binding protein (OSBP) and its closest paralog, OSBP-related protein 4L (ORP4L)--proteins not known to be involved in cancer cell survival. OSBP and the ORPs constitute an evolutionarily conserved protein superfamily, members of which have been implicated in signal transduction, lipid transport and lipid metabolism. The functions of OSBP and the ORPs, however, remain largely enigmatic. Based on our findings, we have named the aforementioned natural products ORPphilins. Here we used ORPphilins to reveal new cellular activities of OSBP. The ORPphilins are powerful probes of OSBP and ORP4L that will be useful in uncovering their cellular functions and their roles in human diseases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158287PMC
http://dx.doi.org/10.1038/nchembio.625DOI Listing

Publication Analysis

Top Keywords

natural products
12
cancer cell
12
osbp orps
8
osbp
5
products reveal
4
reveal cancer
4
cell dependence
4
dependence oxysterol-binding
4
oxysterol-binding proteins
4
proteins cephalostatin
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!